Depomed (DEPO) says that the FDA's website shows that an Abbreviated New Drug Application for a...

|About: Depomed Inc. (DEPO)|By:, SA News Editor

Depomed (DEPO) says that the FDA's website shows that an Abbreviated New Drug Application for a generic version of Zipsor has been submitted. DEPO hasn't received a Paragraph IV certification with respect to the filing and doesn't know the identity of the party that filed. The company says Zipsor is protected by five patents, all of which are listed in the FDA’s Orange Book, and it intends to vigorously enforce its intellectual property rights relating to the drug.